Thyroid gland

Greenfield's Surgery: Scientific Principles and Practice: Fifth Edition

Volumn , Issue , 2012, Pages 1282-1302

  Miller, Barbra S ^a   Gauger, Paul G ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84971515752     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (81)

1. Gauger P, Delbridge LW, Thompson NW, et al. Incidence and importance of the tubercle of Zuckerkandl in thyroid surgery. Eur J Surg 2001;167:249-254.
2. Sackett W, Reeve TS, Barraclough B, et al. Thyrothymic thyroid rests: incidence and relationship to the thyroid gland. J Am Coll Surg 2002;195:635-640.
3. Pelizzo M, Toniato A, Gemo G. Zuckerkandl's tuberculum: an arrow pointing to the recurrent laryngeal nerve (constant anatomical landmark). J Am Coll Surg 1998;187:333-336.
4. Bliss R, Gauger PG, Delbridge LW. Surgeon's approach to the thyroid gland: surgical anatomy and the importance of technique. World J Surg 2000;2:891-897.
5. Katz A. Extralaryngeal division of the recurrent laryngeal nerve. Am J Surg 1986;152:407-410.
6. Henry J, Audiffret J, Denizot A, et al. The nonrecurrent inferior laryngeal nerve: review of 33 cases, including two on he left side. Surgery 1988;104:977-984.
7. Raffaelli M, Iacobone M, Henry JF. The "false" nonrecurrent inferior laryngeal nerve. Surgery 2000;128:1082-1087.
8. Cernea C, Ferraz AR, Nishio S, et al. Surgical anatomy of the external branch of the superior laryngeal nerve. Head Neck 1992;14:380-383.
9. Kupferman ME, Patterson M, Mandel SJ, et al. Patterns of lateral neck metastases in papillary thyroid carcinoma. Arch Otolaryngol Head Neck Surg 2004;130:857-860.
10. Machens A, Holzhausen JJ, Dralle H. Skip metastases in thyroid cancer leaping the central lymph node compartment. Arch Surg 2004;139:43-45.
11. Baskin HJ, Cobin RH, Duick DS, et al.; American Association of Clinical Endocrinologists. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism. Endocr Pract 2002;8:457-569.
12. Scanga DR, Martin WH, Delbeke D. Value of FDG PET imaging in the management of patients with thyroid, neuroendocrine, and neural crest tumors. Clin Nuc Med 2004;29:86-90.
13. Davis P, Perrier ND, Adler L, et al. Incidental thyroid carcinoma identified by positron emission tomography scanning obtained for metastatic evaluation. Am Surg 2001;67:582-584.
14. Katz SC, Shaha A. PET-associated incidental neoplasms of the thyroid. J Am Coll Surg 2008;27:259-264.
15. Boi F, Lai ML, Deias C, et al. The usefulness of 99mTc-SestaMIBI scan in the diagnostic evaluation of thyroid nodules with oncocytic cytology. Eur J Endocrinol 2003;149:493-498.
16. Tan G, Gharib H. Thyroid incidentalomas: management approaches to nonpalpable nodules discovered incidentally on thyroid imaging. Ann Intern Med 1997;126:226-231.
17. Lennquist S, Jortso E, Anderberg B, et al. Beta blockers compared with antithyroid drugs as preoperative treatment in hyperthyroidism: drug tolerance complications, and postoperative thyroid function. Surgery 1985;98:1141-1146.
18. Alderberth A, Stenstrom G, Hasselgren P. The selective beta 1 blocking agent metoprolol compared with antithyroid drug and thyroxine as preoperative treatment of patients with hyperthyroidism. Results from a prospective randomized study. Ann Surg 1987;205:182-188.
19. Tallstedt L, Lundell G, Blomgren H, et al. Does early administration of thyroxine reduce the development of Graves' ophthalmopathy after radioiodine treatment? Eur J Endocrinol 1994;130:494-497.
20. Tallstedt L, Lundell G, Torring O, et al. Occurrence of ophthalmopathy after treatment for Graves' hyperthyroidism. The Thyroid Study Group. N Engl J Med 1992;326:1733-1738.
21. Bartalena L, Marcocci C, Bogazzi F, et al. Use of corticosteroids to prevent progression of Graves' ophthalmopathy after radioiodine therapy for hyperthyroidism. N Engl J Med 1989;321:1349-1352.
22. van Soestbergen M, van der Vijver J, Graafland A. Recurrence of hyperthyroidism in multinodular goiter after long-term drug therapy: a comparison with Graves' disease. J Endocrinol Invest 1992;15:797-800.
23. Repplinger D, Bargren A, Zhang YW, et al. Is Hashimoto's thyroiditis a risk factor for papillary thyroid cancer. J Surg Res 2008;150:49-52.
24. Tunbridge W, Brewis M, French JM, et al. Natural history of autoimmune thyroiditis. Br Med J Clin Res 1981;282:258-262.
25. Smallridge R, DeKeyser FM, VanHerle AJ, et al. Thyroid iodine content and serum thyroglobulin: cues to the natural history of destruction-induced thyroiditis. J Clin Endocrinol Metab 1986;62:1213-1219.
26. Bartalena L, Grasso L, Brogioni S, et al. Serum interleukin-6 in amiodarone-induced thyrotoxicosis. J Clin Endocrinol Metab 1994;78:423-427.
27. Harjai K, Licata AA. Effects of amiodarone on thyroid function. Ann Intern Med 1997;126:63-73.
28. Violaris N, Windle-Taylor PC. Idiopathic fibrosis of the upper aerodigestive tract. J Laryngol Otol 1989;103:333-334.
29. Few J, Thompson NW, Angelos P, et al. Riedel's thyroiditis: treatment with tamoxifen. Surgery 1996;120:998-999.
30. White ML, Doherty GM, Gauger PG. Evidence-based management of substernal goiter. World J Surg 2008;32:1285-1300.
31. Enewold L, Zhu K, Ron E, et al. Rising thyroid cancer incidence in the United States by demographic and tumor characteristics. Cancer Epidemiol Biomarkers Prev 2009;18:784-791.
32. Harness J, Thompson NW, Nishiyama RH. Childhood thyroid carcinoma. Arch Surg 1971;102:278-284.
33. DeGroot L, Kaplan EL, McCormick M, et al. Natural history, treatment, and course of papillary thyroid carcinoma. J Clin Endocrinol Metab 1990;71:414-424.
34. Kebebew E, Clark OH. Differentiated thyroid cancer: "complete" rational approach. World J Surg 2000;24:942-951.
35. Jossart G, Clark OH. Well-differentiated thyroid cancer. Curr Probl Surg 1994;31:933-1012.
36. Ito Y, Tomoda C, Uruno T, et al. Papillary microcarcinoma of the thyroid: how should it be treated? World J Surg 2004;28:1115-1121.
37. Chen H, Nocol TL, Udelsman R. Follicular lesions of the thyroid. Does frozen section evaluation alter operative management? Ann Surg 1995;222:101-106.
38. Emerick G, Duh QY, Siperstein AE, et al. Diagnosis, treatment, and outcome of follicular thyroid carcinoma. Cancer 1993;72:3287-3295.
39. van Heerden J, Hay ID, Goellner JR, et al. Follicular thyroid carcinoma with capsular invasion alone: a non-threatening malignancy. Surgery 1992;112:1130-1138.
40. Thompson N, Nishiyama RH, Harness JK. Thyroid carcinoma: current controversies. Curr Probl Surg 1978;15:1-67.
41. Moley JF, DeBenedetti MK. Patterns of nodal metastases in palpable medullary thyroid carcinoma. Recommendations for extent of node dissection. Ann Surg 1999;229:880-887.
42. Tisell L, Hansson G, Jansson S, et al. Reoperation in the treatment of asymptomatic metastasizing medullary carcinoma of the thyroid. Surgery 1986;99:60-66.
43. Tung WS, Vessely TM, Moley JF. Laparoscopic detection of hepatic metastases in patients with residual or recurrent medullary thyroid cancer. Surgery 1995;118:1024-1029.
44. Fersht N, Vini L, A'Hern R, et al. The role of radiotherapy in the management of elevated calcitonin after surgery for medullary thyroid cancer. Thyroid 2001;11:1161-1168.
45. Skinner M, DeBenedetti MK, Moley JR, et al. Medullary thyroid carcinoma in children with multiple endocrine neoplasia types 2A and 2B. J Pediatr Surg 1996;31:177-181.
46. Crevoisier R, Baudin E, Bachlot A, et al. Combined treatment of anaplastic thyroid carcinoma with surgery, chemotherapy, and hyperfractionated accelerated external radiotherapy. Int J Radiat Oncol Biol Phys 2004;60:1137-1143.
47. Mack LA, Pasieka JL. An evidence-based approach to the treatment of thyroid lymphoma. World J Surg 2007;31:978-986.
48. Green LD, Mack L, Pasieka JL. Anaplastic thyroid cancer and primary thyroid lymphoma: a review of these rare thyroid malignancies. J Surg Oncol 2006;94:725-736.
49. Dai CW, Zhang GS, Pei MF, et al. Thyroid diffuse large B cell lymphoma (DLBCL) following thyroid medullary cancer: long-term complete remission with R-CHOP therapy. Ann Hematol 2009;88:701-702.
50. Sippel R, Gauger PG, Angelos P, et al. Palliative thyroidectomy for malignant lymphoma of the thyroid. Ann Surg Oncol 2002;9:907-911.
51. Mirallie E, Rigaud J, Mathonnet M, et al. Management and prognosis of metastases to the thyroid gland. J Am Coll Surg 2005;200:203-207.
52. Hay I, Grant CS, Taylor WF, et al. Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: a retrospective analysis of surgical outcome using a novel prognostic scoring system. Surgery 1987;102:1088-1095.
53. Cady B, Rossi R. An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery 1988;104:947-953.
54. Hay I, Bergstralh EJ, Goellner JR, et al. Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 1993;114:1050-1057.
55. Byar D, Green SB, Dor P, et al. A prognostic index for thyroid carcinoma: a study of the E.O.R.T.C. thyroid cancer cooperative group. Eur J Cancer 1979;15:1033-1041.
56. Bilimoria K, Bentrem DJ, Ko CY, et al. Extent of surgery affects survival for papillary thyroid cancer. Ann Surg 2007;246(3):375-384.
57. Grebe S, Hay ID. Thyroid cancer nodal metastasis: biologic significance and therapeutic considerations. Surg Oncol Clin N Am 1996;5:43-63.
58. Loh K, Greenspan FS, Gee L, et al. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients. J Clin Endocrinol Metab 1997;82:3553-3562.
59. Cooper D, Doherty GM, Haugen BR, et al. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2006;16(2):109-142.
60. White ML, Gauger PG, Doherty GM. Central lymph node dissection in differentiated thyroid cancer. World J Surg 2007;31:895-904.
61. Sywak M, Cornford L, Roach P, et al. Routine ipsilateral level VI lymphadenectomy reduces postoperative thyroglobulin levels in papillary thyroid cancer. Surgery 2006;140:1000-1007.
62. Stulak JM, Grant CS, Farley DR, et al. Value of preoperative ultrasonography in the surgical management of initial and reoperative papillary thyroid cancer. Arch Surg 2006;141(5):494-496.
63. Kouvaraki MA, Shapiro SE, Fornage BD, et al. Role of preoperative ultrasonography in the surgical management of patients with thyroid cancer. Surgery 2003;134(6):946-955.
64. Solorzano CC, Carneiro DM, Ramirez M, et al. Surgeon-performed ultrasound in the management of thyroid malignancy. Am Surg 2004;70(7): 580-582.
65. Mazzaferri EL, Kloos RT. Using recombinant human TSH in the management of well-differentiated thyroid cancer: current strategies and future directions. Thyroid 2000;10(9):767-778.
66. Mazzaferri E. Thyroid remnant 131 I ablation for papillary and follicular thyroid carcinoma. Thyroid 1997;7:265-271.
67. Mazzaferri EL, Jhiang SM, Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 1994;97:418-428.
68. Brierley J, Tsang RW. External-beam radiation therapy in the treatment of differentiated thyroid cancer. Semin Surg Oncol 1999;16:42-49.
69. Hunt J. Molecular testing in solid tumors. Arch Pathol Lab Med 2008;132:164-167.
70. Henderson Y, Soon-Hyun A, Kang Y, et al. Sorafenib potently inhibits papillary thyroid carcinomas harboring RET/PTC1 rearrangement. Clin Cancer Res 2008;14(15):4908-4914.
71. Miccoli P, Minuto MN, Ugolini C, et al. Minimally invasive video-assisted thyroidectomy for benign thyroid disease: an evidence-based review. World J Surg 2008;32:1333-1340.
72. Miccoli P, Berti P, Raffaelli G, et al. Comparison between minimally invasive video-assisted thyroidectomy and conventional thyroidectomy: a prospective randomized study. Surgery 2001;130:1039-1043.
73. Alvarado R, McMullen T, Sidhu SB, et al. Minimally invasive thyroid surgery for single nodules: an evidence-based review of the lateral mini-incision technique. World J Surg 2008;32:1341-1348.
74. Jeryong K, Jinsun L, Hyegyong K, et al. Total endoscopic thyroidectomy with bilateral breast areola and ipsilateral axillary (BBIA) approach. World J Surg 2008;32:2488-2493.
75. Franko J, Kish KJ, Pezzi CM, et al. Safely increasing the efficiency of thyroidectomy using a new bipolar electrosealing device (LigaSure) versus conventional clamp-and-tie technique. Am Surg 2006;72:132-136.
76. Siperstein A, Berber E, Morkoyun E. The use of the harmonic scalpel vs. conventional knot tying for vessel ligation in thyroid surgery. Arch Surg 2002;137:137-142.
77. Cardon C, Fajardo R, Ramirez J. A randomized, prospective, parallel group study comparing the harmonic scalpel to electrocautery in thyroidectomy. Surgery 2005;137:337-3341.
78. Teitelbaum B, Wenig BL. Superior laryngeal nerve injury from thyroid surgery. Head Neck 1995;17:36-340.
79. Dralle H, Sekulla C, Haerting J, et al. Risk factors of paralysis and functional outcome after recurrent laryngeal nerve monitoring in thyroid surgery. Surgery 2004;136:1310-1322.
80. Yarbrough D, Thompson GB, Kasperbauer JL, et al. Intraoperative electromyographic monitoring of the recurrent laryngeal nerve in reoperative thyroid and parathyroid surgery. Surgery 2004;136:1107-1115.
81. Gauger P, Reeve TS, Wilkinson M, et al. Routine parathyroid autotransplantation during total thyroidectomy: the influence of technique. Eur J Surg 2000;166:605-609.